semaglutide intestinal paralysis law office in kentucky gastrointestinal obstruction kentucky semaglutide side effect law firm Ozempic Lawsuit for Blindness, Stomach and Injury Claims semaglutide stomach paralysis law firm

Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist approved by the FDA for type 2 diabetes management (under the brand name Ozempic) and chronic weight management (as Wegovy)

Call urgently for severe abdominal pain, especially with persistent vomiting

Its development marks a strategic pivot toward oral-first therapeutic models, potentially redefining the landscape of metabolic disease management while alleviating global supply chain limitations

However, currently available data indicate that this disinterest in high-calorie products (and overconsumption of food in general) is reversible and that stopping treatment quickly leads to a regain of most of the weight initially lost